These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15706352)

  • 1. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPP1 and ASPP2 are new transcriptional targets of E2F.
    Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
    Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM is a target for positive regulation by E2F-1.
    Berkovich E; Ginsberg D
    Oncogene; 2003 Jan; 22(2):161-7. PubMed ID: 12527885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53.
    Stanelle J; Tu-Rapp H; Pützer BM
    Cell Death Differ; 2005 Apr; 12(4):347-57. PubMed ID: 15565177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress signals induce transcriptionally inactive E2F-1 independently of p53 and Rb.
    O'Connor DJ; Lu X
    Oncogene; 2000 May; 19(20):2369-76. PubMed ID: 10828878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
    Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
    Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC; Hickman ES; Lazzerini Denchi E; Caprara G; Colli E; Cecconi F; Müller H; Helin K
    Nat Cell Biol; 2001 Jun; 3(6):552-8. PubMed ID: 11389439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS; Wiman KG
    Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
    Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
    Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
    Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
    Nip J; Strom DK; Eischen CM; Cleveland JL; Zambetti GP; Hiebert SW
    Oncogene; 2001 Feb; 20(8):910-20. PubMed ID: 11314026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.
    Kong HJ; Yu HJ; Hong S; Park MJ; Choi YH; An WG; Lee JW; Cheong J
    Mol Cancer Res; 2003 Nov; 1(13):948-58. PubMed ID: 14638867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.